EDAP TMS S.A PE Ratio 2010-2024 | EDAP
Current and historical p/e ratio for EDAP TMS S.A (EDAP) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. EDAP TMS S.A PE ratio as of November 07, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| EDAP TMS S.A PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-11-07 | 2.73 | 0.00 | |
| 2023-12-31 | 5.28 | $-0.63 | 0.00 |
| 2023-09-30 | 7.02 | $-0.62 | 0.00 |
| 2023-06-30 | 9.22 | $-0.50 | 0.00 |
| 2023-03-31 | 11.07 | $-0.30 | 0.00 |
| 2022-12-31 | 10.66 | $-0.07 | 0.00 |
| 2022-09-30 | 8.25 | $0.11 | 75.00 |
| 2022-06-30 | 6.80 | $0.09 | 75.56 |
| 2022-03-31 | 7.25 | $0.06 | 120.83 |
| 2021-12-31 | 5.99 | $0.08 | 74.88 |
| 2021-06-30 | 7.09 | $-0.00 | 0.00 |
| 2021-03-31 | 8.40 | $0.01 | 0.00 |
| 2020-12-31 | 5.17 | $-0.07 | 0.00 |
| 2020-09-30 | 4.60 | $-0.06 | 0.00 |
| 2020-06-30 | 2.47 | $0.01 | 247.43 |
| 2020-03-31 | 2.27 | $0.07 | 32.43 |
| 2019-12-31 | 4.43 | $0.13 | 34.08 |
| 2019-09-30 | 4.49 | $0.13 | 34.54 |
| 2019-06-30 | 2.70 | $0.07 | 38.57 |
| 2019-03-31 | 3.00 | $-0.01 | 0.00 |
| 2018-12-31 | 1.85 | $-0.02 | 0.00 |
| 2018-09-30 | 3.08 | $-0.06 | 0.00 |
| 2018-06-30 | 3.03 | $-0.05 | 0.00 |
| 2018-03-31 | 2.32 | $-0.09 | 0.00 |
| 2017-12-31 | 2.87 | $-0.03 | 0.00 |
| 2017-09-30 | 2.98 | $-0.08 | 0.00 |
| 2017-06-30 | 3.30 | $-0.01 | 0.00 |
| 2017-03-31 | 2.77 | $0.15 | 18.47 |
| 2016-12-31 | 3.28 | $0.15 | 21.87 |
| 2016-09-30 | 2.90 | $0.39 | 7.44 |
| 2016-06-30 | 3.31 | $0.12 | 27.58 |
| 2016-03-31 | 4.02 | $0.05 | 80.40 |
| 2015-12-31 | 4.13 | $-0.12 | 0.00 |
| 2015-09-30 | 5.59 | $-0.44 | 0.00 |
| 2015-06-30 | 3.25 | $0.11 | 29.55 |
| 2015-03-31 | 3.63 | $-0.23 | 0.00 |
| 2014-12-31 | 2.33 | $-0.07 | 0.00 |
| 2014-09-30 | 1.31 | $0.02 | 65.50 |
| 2014-06-30 | 4.98 | $-0.33 | 0.00 |
| 2014-03-31 | 2.86 | $-0.02 | 0.00 |
| 2013-12-31 | 2.95 | $-0.34 | 0.00 |
| 2013-09-30 | 2.53 | $-0.38 | 0.00 |
| 2013-06-30 | 2.72 | $-0.39 | 0.00 |
| 2013-03-31 | 4.17 | $-0.57 | 0.00 |
| 2012-12-31 | 2.04 | $-0.52 | 0.00 |
| 2012-09-30 | 1.71 | $-0.50 | 0.00 |
| 2012-06-30 | 1.94 | $-0.38 | 0.00 |
| 2012-03-31 | 1.90 | $-0.35 | 0.00 |
| 2011-12-31 | 1.69 | $-0.11 | 0.00 |
| 2011-09-30 | 1.75 | $-0.79 | 0.00 |
| 2011-06-30 | 3.28 | $-1.10 | 0.00 |
| 2011-03-31 | 3.49 | $-1.06 | 0.00 |
| 2010-12-31 | 5.64 | $-1.40 | 0.00 |
| 2010-09-30 | 2.41 | $-0.43 | 0.00 |
| 2010-06-30 | 2.33 | $-1.01 | 0.00 |
| 2010-03-31 | 3.16 | $-0.96 | 0.00 |
| 2009-12-31 | 2.75 | $-1.06 | 0.00 |
| 2009-09-30 | 4.00 | $-1.47 | 0.00 |
| 2009-06-30 | 1.50 | $-0.80 | 0.00 |
| 2009-03-31 | 1.50 | $-0.77 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.101B | $0.065B |
| EDAP TMS S.A. develops, produces, markets and distributes minimally invasive medical devices, primarily for the treatment of urological diseases. They currently produce and market devices for treatment of benign prostate hyperplasia and urinary tract stones. They are also developing a third range of products for minimally invasive destruction of certain types of tumors. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $212.628B | 25.94 |
| Intuitive Surgical (ISRG) | United States | $186.738B | 97.63 |
| Alcon (ALC) | Switzerland | $45.674B | 32.15 |
| IQVIA Holdings (IQV) | United States | $39.509B | 21.77 |
| Edwards Lifesciences (EW) | United States | $38.832B | 24.66 |
| IDEXX Laboratories (IDXX) | United States | $35.456B | 41.76 |
| DexCom (DXCM) | United States | $26.916B | 40.53 |
| Waters (WAT) | United States | $22.926B | 33.90 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.977B | 0.00 |
| STERIS (STE) | Ireland | $21.252B | 24.49 |
| Hologic (HOLX) | United States | $18.417B | 19.43 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.517B | 12.85 |
| Sysmex ADR (SSMXY) | Japan | $12.405B | 38.90 |
| Globus Medical (GMED) | United States | $11.099B | 28.27 |
| Teleflex (TFX) | United States | $9.197B | 14.67 |
| Penumbra (PEN) | United States | $8.945B | 87.62 |
| Masimo (MASI) | United States | $8.639B | 41.80 |
| Glaukos (GKOS) | United States | $7.682B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.022B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.514B | 25.59 |
| Inari Medical (NARI) | United States | $3.035B | 0.00 |
| TransMedics (TMDX) | United States | $2.870B | 90.96 |
| Veracyte (VCYT) | United States | $2.868B | 86.84 |
| LivaNova (LIVN) | United Kingdom | $2.823B | 16.30 |
| Nihon Kohden (NHNKY) | Japan | $2.488B | 18.90 |
| Elekta AB (EKTAY) | Sweden | $2.336B | 19.03 |
| Tandem Diabetes Care (TNDM) | United States | $2.188B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.968B | 10.29 |
| RxSight (RXST) | United States | $1.881B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.334B | 0.00 |
| Artivion (AORT) | United States | $1.214B | 80.50 |
| Pulse Biosciences (PLSE) | United States | $1.106B | 0.00 |
| OPKO Health (OPK) | United States | $1.011B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.939B | 15.96 |
| IRadimed (IRMD) | United States | $0.707B | 38.23 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.696B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.668B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.666B | 0.00 |
| SiBone (SIBN) | United States | $0.649B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.638B | 15.10 |
| Paragon 28 (FNA) | United States | $0.591B | 0.00 |
| AxoGen (AXGN) | United States | $0.582B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.492B | 0.00 |
| CVRx (CVRX) | United States | $0.377B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.370B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.366B | 19.81 |
| Delcath Systems (DCTH) | United States | $0.304B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.291B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.276B | 18.50 |
| Sight Sciences (SGHT) | United States | $0.235B | 0.00 |
| Inogen (INGN) | United States | $0.224B | 0.00 |
| NeuroPace (NPCE) | United States | $0.221B | 0.00 |
| Accuray (ARAY) | United States | $0.210B | 0.00 |
| Nevro (NVRO) | United States | $0.199B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.189B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.156B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.129B | 0.00 |
| 908 Devices (MASS) | United States | $0.126B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.114B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.107B | 15.95 |
| WORK Medical Technology Group (WOK) | China | $0.090B | 0.00 |
| LENSAR (LNSR) | United States | $0.080B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.079B | 0.00 |
| Hyperfine (HYPR) | United States | $0.070B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | Israel | $0.059B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.054B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.047B | 0.00 |
| Envoy Medical (COCH) | United States | $0.040B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Neuronetics (STIM) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.029B | 0.00 |
| Precision Optics (POCI) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.025B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.014B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |